Stereotaxis, Inc.

Healthcare

AMEX:STXS · New York Stock Exchange American

Market Cap $183.74M Beta 1.32 P/E (TTM) -8.3

$1.88 +2.53%

+$0.05 today

52W Low $1.70High $3.59

Vol 0.58M · Avg 0.39M

EPS (TTM) -$0.22Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-10.90%

Period High

$3.57

Period Low

$1.73

Latest

$1.88

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

OraSure Technologies, Inc.

NASDAQ:OSUR

$301.21M

NeoGenomics, Inc.

NASDAQ:NEO

$289.07M

Sagimet Biosciences Inc.

NASDAQ:SGMT

$216.81M

Arcturus Therapeutics Holdings Inc.

NASDAQ:ARCT

$213.17M

Sanara MedTech Inc.

NASDAQ:SMTI

$200.05M

Quanterix Corporation

NASDAQ:QTRX

$158.28M

Humacyte, Inc.

NASDAQ:HUMA

$157.32M

CVRx, Inc.

NASDAQ:CVRX

$131.09M

Exagen Inc.

NASDAQ:XGN

$105.46M

MDxHealth S.A.

MDXH

$28.26M

What is the latest STXS filing?

The latest filing shown is SD dated May 29, 2026.

How many recent filings does STXS have?

Intrinsic Alpha currently shows 20 recent filings for STXS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.